HLA

Scope & Guideline

Elevating Immunology: Where Research Meets Accessibility

Introduction

Welcome to the HLA information hub, where our guidelines provide a wealth of knowledge about the journal’s focus and academic contributions. This page includes an extensive look at the aims and scope of HLA, highlighting trending and emerging areas of study. We also examine declining topics to offer insight into academic interest shifts. Our curated list of highly cited topics and recent publications is part of our effort to guide scholars, using these guidelines to stay ahead in their research endeavors.
LanguageEnglish
ISSN2059-2302
PublisherWILEY
Support Open AccessNo
CountryUnited Kingdom
TypeJournal
Converge2011, from 2016 to 2024
AbbreviationHLA / HLA
Frequency12 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
Address111 RIVER ST, HOBOKEN 07030-5774, NJ

Aims and Scopes

The journal 'HLA' focuses on the study of human leukocyte antigens (HLA) and their implications for immunology, transplantation, and disease associations. It serves as a platform for disseminating research that advances the understanding of HLA genetics, molecular biology, and clinical applications.
  1. Characterization of Novel HLA Alleles:
    The journal emphasizes the identification and characterization of new HLA alleles through advanced sequencing techniques, which are crucial for understanding genetic diversity and its implications in transplantation and disease susceptibility.
  2. HLA and Disease Associations:
    Research on the association between specific HLA alleles and various diseases, including autoimmune disorders, infectious diseases, and cancers, is a core focus. This includes studies linking HLA polymorphisms to clinical outcomes and disease severity.
  3. Transplantation Immunology:
    The journal covers topics related to HLA's role in transplantation, particularly in understanding donor-recipient compatibility, the development of donor-specific antibodies, and strategies for improving transplant outcomes.
  4. Molecular and Genetic Techniques:
    A significant portion of the research employs next-generation sequencing and other molecular techniques to explore HLA genetics, focusing on high-resolution typing and the implications of genetic variations.
  5. Immunogenetics and Personalized Medicine:
    The integration of immunogenetics into personalized medicine approaches, particularly in transplantation and autoimmune diseases, is a growing area of interest, reflecting the journal's commitment to translational research.
The journal is experiencing a dynamic evolution in its focus areas, with several emerging themes gaining prominence. These trends reflect advancements in technology and shifts in clinical practice.
  1. Next-Generation Sequencing Applications:
    The use of next-generation sequencing for HLA typing and allele discovery is increasingly prominent, enabling more efficient and accurate identification of alleles and enhancing understanding of genetic diversity.
  2. HLA in COVID-19 Research:
    Research linking HLA alleles to COVID-19 susceptibility and outcomes is rapidly emerging, reflecting the pandemic's impact on immunogenetics and highlighting the relevance of HLA in infectious disease response.
  3. Immunogenetic Factors in Transplant Outcomes:
    There is a growing trend towards researching the impact of specific HLA alleles and haplotypes on transplant outcomes, particularly in relation to donor-specific antibodies and graft-versus-host disease.
  4. Integration of Machine Learning in HLA Studies:
    The application of machine learning techniques in analyzing HLA data for predicting transplant outcomes and understanding immunological responses is emerging as a significant trend, indicating a shift towards data-driven approaches.
  5. Personalized Medicine in Transplantation:
    Increasingly, studies are focusing on personalized medicine approaches in transplantation, including the customization of immunosuppressive therapies based on HLA profiles and patient-specific factors.

Declining or Waning

While the journal has seen significant growth in certain areas, there are themes that appear to be declining in prominence. These waning scopes indicate shifts in research focus or decreased publication activity.
  1. HLA Typing Methodologies:
    Research specifically centered on traditional HLA typing methodologies seems to be declining, as there is a noticeable shift towards next-generation sequencing and more advanced molecular techniques.
  2. HLA Antibody Detection Techniques:
    The exploration of older methodologies for HLA antibody detection, such as complement-dependent cytotoxicity assays, has seen reduced publication frequency as newer, more sensitive techniques gain traction.
  3. General HLA Research without Specific Clinical Application:
    There appears to be a waning interest in purely academic studies of HLA without direct clinical implications, as the focus shifts towards translational research that can impact patient care and treatment outcomes.

Similar Journals

Molecular Biology Research Communications

Cultivating collaboration in the evolving landscape of molecular research.
Publisher: SHIRAZ UNIVISSN: 2322-181XFrequency: 4 issues/year

Molecular Biology Research Communications is a distinguished academic journal published by Shiraz University, focusing on the critical and rapidly evolving fields of biochemistry and molecular biology. With an ISSN of 2322-181X and an E-ISSN of 2345-2005, this journal serves as an essential platform for researchers, professionals, and students to disseminate significant findings that contribute to the advancement of knowledge in these disciplines. The journal, operating from Shiraz, Iran, is notable for its contributions from both local and international scholars, offering invaluable insights and fostering scientific collaboration. Although currently indexed in the Q4 quartile across its categories, the journal aims to enhance its impact and visibility in the field as it converges years of research from 2017 to 2024. While the open access option is not available, the journal's commitment to high-quality peer-reviewed research provides a respected avenue for publication.

Human Genomics

Connecting Innovators in Genetic Research
Publisher: BMCISSN: 1473-9542Frequency: 1 issue/year

Human Genomics, published by BMC, is a leading open-access journal dedicated to advancing the field of genomics and its applications in health and disease. Since its inception in 2003, the journal has provided a vital platform for researchers to disseminate groundbreaking findings related to genetic research, contributing significantly to areas such as Drug Discovery, Genetics, Molecular Biology, and Molecular Medicine, as reflected in its Q1 and Q2 quartile rankings throughout 2023. With an ISSN of 1473-9542 and an E-ISSN of 1479-7364, Human Genomics not only delivers high-quality, peer-reviewed research but also ensures accessibility to a broader audience, empowering professionals, students, and academics to stay at the forefront of genomic science. Through its rigorous editorial standards and impactful publications, the journal fosters a collaborative environment for innovative research across the globe from its base in the United Kingdom. By promoting open access since its launch, Human Genomics continues to enhance the visibility and impact of genetic studies, making it an essential resource for anyone involved in the rapidly evolving field of human genomics.

International Journal of Immunogenetics

Catalyzing Discoveries in Immune System Research
Publisher: WILEYISSN: 1744-3121Frequency: 6 issues/year

International Journal of Immunogenetics, under the esteemed publication house WILEY, serves as a pivotal platform for researchers and professionals in the fields of immunology and genetics. With an ISSN of 1744-3121 and an E-ISSN of 1744-313X, this journal offers a rich repository of scholarly articles and research findings that advance our understanding of immune system genetics. Hailing from the United Kingdom, the journal maintains an impactful presence with category quartiles reflecting a Q3 rating in Genetics and Immunology and a Q2 in Medicine (miscellaneous), positioning it as a credible source of scientific knowledge. It encompasses studies from converged years ranging from 1974 to 1996 and again from 2005 to 2024, ensuring a robust collection of both historical and contemporary research. Researchers are encouraged to engage with its content, given its Scopus rankings—highlighting the journal’s relevance in a competitive academic landscape. As an open-access title, International Journal of Immunogenetics strives to enhance accessibility to vital research, fostering collaboration and innovation in the genetic and immunological domains.

Gene Reports

Bridging Research and Application in Genetics
Publisher: ELSEVIERISSN: Frequency: 4 issues/year

Gene Reports is a prominent academic journal published by Elsevier that focuses on the rapidly evolving field of genetics. Launched in 2015, this journal serves as a pivotal platform for the dissemination of cutting-edge research, bridging the gap between basic and applied genetics studies. Although it currently holds a Q4 ranking in the Genetics category and stands at the 248th position out of 347 in Scopus rankings, its potential for growth is significant given the increasing interest in genetic research across various disciplines. With an E-ISSN of 2452-0144, Gene Reports aims to provide open access to original research articles, reviews, and short communications that advance the collective understanding of genetic mechanisms and their applications. As a publication that continues to shape the future of genetics, it is an essential resource for researchers, professionals, and students seeking to stay informed about the latest developments in this crucial field.

EXPERT REVIEW OF MOLECULAR DIAGNOSTICS

Connecting Experts for Groundbreaking Discoveries
Publisher: TAYLOR & FRANCIS ASISSN: 1473-7159Frequency: 12 issues/year

EXPERT REVIEW OF MOLECULAR DIAGNOSTICS, published by Taylor & Francis AS, serves as a pivotal platform for facilitating advanced research and discourse in the fields of Genetics, Molecular Biology, Molecular Medicine, and Pathology. With an impressive Impact Factor and a distinguished status as Q2 in multiple categories, along with a prestigious Q1 ranking in Pathology and Forensic Medicine (2023), this journal continues to attract contributions from leading experts and budding researchers alike. The journal aims to address critical developments in molecular diagnostics, providing insightful reviews that propel the understanding and application of diagnostic techniques in various medical contexts. Accessible to a diverse audience in the academic community, the journal emphasizes the importance of molecular diagnostics in both clinical and laboratory settings, promoting innovative methodologies and comprehensive evaluations of emerging technologies. With ongoing convergence of scientific discovery advancing rapidly from 2001 through 2024, EXPERT REVIEW OF MOLECULAR DIAGNOSTICS remains essential for those committed to furthering the fields of molecular diagnostics and healthcare advancements globally.

Global Medical Genetics

Exploring the Intersection of Genetics and Healthcare
Publisher: GEORG THIEME VERLAG KGISSN: 2699-9404Frequency: 4 issues/year

Global Medical Genetics is a premier open-access journal dedicated to advancing the field of medical genetics. Published by GEORG THIEME VERLAG KG, this journal has been providing a dynamic platform for disseminating cutting-edge research and clinical findings since its inception in 2020. With the ISSN 2699-9404, it serves as an essential resource for researchers, healthcare professionals, and students who seek to explore the complex interplay between genetics and medicine. The journal aims to foster collaboration and innovation in the genetics community, addressing a diverse range of topics from genetic disorders to the application of genomics in personalized medicine. By providing open access to its content, Global Medical Genetics enhances knowledge sharing and accelerates advancements in healthcare, making it a vital asset for anyone invested in the future of genetics.

Molecular Genetics & Genomic Medicine

Pioneering research for a healthier tomorrow.
Publisher: WILEYISSN: 2324-9269Frequency: 12 issues/year

Molecular Genetics & Genomic Medicine, published by WILEY, is an esteemed and open-access journal that has been a prominent source of knowledge in the fields of genetics and molecular biology since its establishment in 2013. With an ISSN of 2324-9269, it aims to provide a platform for the dissemination of novel findings and innovative research that pushes the boundaries of genomics and its clinical applications. The journal holds a Q3 categorization in Genetics, Clinical Genetics, and Molecular Biology, reflecting its growing influence in these disciplines, as evidenced by its Scopus rankings. Researchers, professionals, and students alike will find valuable insights and advancements in genomic medicine, making this journal an essential resource for those dedicated to the understanding and application of genetic and molecular research in healthcare. Located at 111 River St, Hoboken, NJ, Molecular Genetics & Genomic Medicine continues to foster a global dialogue within the scientific community, ensuring accessible knowledge for all.

IMMUNOLOGICAL INVESTIGATIONS

Elevating Immunological Knowledge for Professionals and Scholars
Publisher: TAYLOR & FRANCIS INCISSN: 0882-0139Frequency: 8 issues/year

IMMUNOLOGICAL INVESTIGATIONS, published by Taylor & Francis Inc, is a leading journal in the field of immunology and related medical sciences, with an established presence since 1972. With a focus on cutting-edge research and critical insights in immunological methods and theories, this journal serves as a pivotal platform for researchers, professionals, and students alike. Though it currently holds a Q3 ranking in Immunology and a Q2 ranking in miscellaneous medicine as of 2023, its Scopus rank of #129 out of 236 reflects its dedication to advancing the understanding of immune responses and therapies. The journal's commitment to rigorous peer review and high-quality publications enables it to remain relevant and influential in the ever-evolving landscape of immunological research. Subscription is required to access its extensive archive, which spans critical developments in the field of immunology from 1972 to 2024.

Human Genetics and Genomics Advances

Connecting Researchers, Empowering Insights
Publisher: ELSEVIERISSN: 2666-2477Frequency:

Human Genetics and Genomics Advances is a premier academic journal published by Elsevier, dedicated to the field of human genetics and genomic medicine. With an ISSN of 2666-2477, this journal has quickly established itself as a leading platform for disseminating cutting-edge research from its inception in 2020. Featured prominently in Q1 categories for both Clinical Genetics and Molecular Medicine as of 2023, it ranks favorably among its peers, reflected in its Scopus rankings. The journal not only offers valuable insights into the latest advancements and applications in genetics but also facilitates open dialogue among researchers, clinicians, and students. As an open access publication, it ensures that groundbreaking findings in genetics are readily accessible to a global audience, promoting knowledge sharing and collaboration. Human Genetics and Genomics Advances continues to be instrumental in moving the field forward, providing a vital resource for those at the forefront of genetic and genomic research.

GENETICS IN MEDICINE

Elevating Standards in Genetic Medicine
Publisher: ELSEVIER SCIENCE INCISSN: 1098-3600Frequency: 12 issues/year

GENETICS IN MEDICINE, published by Elsevier Science Inc, stands as a premier journal in the realms of clinical genetics and medicine. With an impressive impact factor and ranked #3 out of 99 in the category of Genetics (clinical), alongside a 97th percentile ranking in the Scopus database, this journal is recognized for its outstanding contribution to the field. Established in 1998, it aims to disseminate innovative research and clinical advancements bridging genetics and medical practice, making it essential reading for researchers, healthcare professionals, and students alike. Although not an open-access journal, GENETICS IN MEDICINE provides valuable insights into genetics that drive the future of personalized medicine and patient care. With a commitment to excellence, the journal continuously explores the evolving landscape of genetic research to foster the understanding and application of genetic principles in medical contexts.